Skip to main content

Peer Review reports

From: Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8

Original Submission
11 Jul 2017 Submitted Original manuscript
8 Aug 2017 Reviewed Reviewer Report - Sameer Mirza
8 Aug 2017 Reviewed Reviewer Report - Shiladitya Sengupta
9 Aug 2017 Reviewed Reviewer Report - Bhopal Mohapatra
6 Nov 2017 Author responded Author comments - Chanitra Thuwajit
Resubmission - Version 2
6 Nov 2017 Submitted Manuscript version 2
13 Dec 2017 Author responded Author comments - Rochanawan Sootichote
Resubmission - Version 3
13 Dec 2017 Submitted Manuscript version 3
19 Dec 2017 Author responded Author comments - Rochanawan Sootichote
Resubmission - Version 4
19 Dec 2017 Submitted Manuscript version 4
20 Dec 2017 Author responded Author comments - Rochanawan Sootichote
Resubmission - Version 5
20 Dec 2017 Submitted Manuscript version 5
Publishing
20 Feb 2018 Editorially accepted
27 Feb 2018 Article published 10.1186/s12885-018-4155-6

You can find further information about peer review here.

Back to article page